Immediate Impact
62 standout
Citing Papers
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Works of Giulia Magini being referenced
NAFLD and MAFLD as emerging causes of HCC: A populational study
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Giulia Magini | 149 | 137 | 46 | 48 | 28 | 248 | |
| Yasuhiko Nakao | 56 | 123 | 34 | 46 | 29 | 243 | |
| Myung Ji Goh | 130 | 139 | 40 | 53 | 31 | 233 | |
| Howard H.W. Leung | 131 | 188 | 24 | 21 | 25 | 272 | |
| Vladimir Marquez | 140 | 97 | 79 | 25 | 30 | 241 | |
| Renjia Zhao | 52 | 141 | 35 | 44 | 20 | 225 | |
| Wei Wei | 88 | 109 | 32 | 34 | 37 | 285 | |
| Nicoletta De Matthaeis | 145 | 124 | 61 | 15 | 21 | 235 | |
| Chikaharu Sakata | 139 | 74 | 108 | 27 | 24 | 266 | |
| Ryosaku Azemoto | 134 | 108 | 68 | 29 | 19 | 275 | |
| Mahyar Mohammadifard | 48 | 85 | 43 | 16 | 32 | 205 |
All Works
Login with ORCID to disown or claim papers
Loading papers...